Newsroom

Benefit Advisors Network (BAN), an international network of employee benefit brokers and consulting firms has developed a strategic partnership with Truveris.

On May 17, 2022, the U.S. District Court for DC ruled against the “accumulator adjustment rule.” What impact will this have on pharma?

Truveris announces the launch of oneRx, the only drug price transparency solution that helps members navigate their pharmacy benefits.

The State of Minnesota has selected Truveris as its exclusive pharmacy benefits procurement and oversight partner for 52,000 employees.

Truveris announced today that Nanette Oddo, formerly Truveris’ Chief Strategy Officer, has been named President and Chief Executive Officer.

Several states have passed copay accumulator laws that prohibit the use of copay accumulator adjustment programs. How does this affect your organization?

The Truveris leadership team has expanded to include six seasoned healthcare and technology veterans.

In October of 2017, Anthem Inc. announced its launching of IngenioRx, an in-house pharmacy benefits manager (PBM).